ISB News

Postdoc Appreciation 2017

Postdoc Appreciation 2017

In honor of National Postdoc Appreciation Week in late September, ISB’s staff recently gathered to honor and celebrate all of our devoted and hardworking postdocs. The event included speeches from a number of faculty members. “Postdocs are the heart of ISB,” Dr. Nathan Price, professor and associate director, told the gathering. “I say that as a former postdoc,” he joked. Dr. Nitin Baliga, ISB’s senior vice president and director, affectionately told the postdocs they are “the boots on the ground” of the many different research areas around our organization.

Postdocs from all nine faculty lab groups were honored. They include: Ajay Akhade, Mario Arrieta-Ortiz, Priyanka Baloni, Rhishikesh Bargaje, Nyasha Chambwe, Vikas Ghai, Isil Hamdemir, Henry Hampton, Laura Heath, Neda Jabbari, Guenther Kahlert, Sanjeev Kumar, Sarah Kwon, Minyoung Lee, Mukul Midha, Annie Otwell, Jaipal Panga, James Park, Matt Richards, Leah Rommereim, Martin Shelton, Vivek Srinivas, Jacob Valenzuela, and Matt Wall.

Recent Articles

  • Timing is Everything: ISB Study Finds Link Between Bowel Movement Frequency and Overall Health

    Everybody poops, but not every day. An ISB-led research team examined the clinical, lifestyle, and multi-omic data of more than 1,400 healthy adults. How often people poop, they found, can have a large influence on one’s physiology and health.

  • Wei Wei, PhD

    Dr. Wei Wei Promoted to Associate Professor

    Wei Wei, PhD – an accomplished cancer researcher with expertise in biotechnology and cancer systems biology – has been promoted to ISB associate professor. The Wei Lab focuses on understanding how cancer cells adapt to therapeutic treatment to foster therapy resistance by coordinating their internal molecular machinery and how these adaptive changes evolve within diverse tumors influenced by the tumor microenvironment. 

  • Drs. Nitin Baliga and James Park

    How Glioblastoma Resists Treatment – and Ways to Prevent It

    Glioblastoma is one of the deadliest and most aggressive forms of primary brain cancer in adults and is known for its ability to resist treatment and to recur. ISB researchers have made breakthrough discoveries in understanding the mechanisms behind acquired resistance, focusing on a rare and stubborn group of cells within tumors called glioma stem-like cells.